- Home
- PYPD vs VRAR Comparison
PYPD vs VRAR Comparison
Compare PYPD & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- VRAR
- Stock Information
- Founded
- PYPD 2008
- VRAR 2016
- Country
- PYPD Israel
- VRAR United States
- Employees
- PYPD N/A
- VRAR N/A
- Industry
- PYPD Medical/Dental Instruments
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- PYPD Health Care
- VRAR Technology
- Exchange
- PYPD Nasdaq
- VRAR Nasdaq
- Market Cap
- PYPD 35.3M
- VRAR 33.3M
- IPO Year
- PYPD 2020
- VRAR 2021
- Fundamental
- Price
- PYPD $3.58
- VRAR $1.33
- Analyst Decision
- PYPD Strong Buy
- VRAR Strong Buy
- Analyst Count
- PYPD 5
- VRAR 1
- Target Price
- PYPD $11.40
- VRAR $2.62
- AVG Volume (30 Days)
- PYPD 1.4M
- VRAR 139.2K
- Earning Date
- PYPD 08-13-2025
- VRAR 05-15-2025
- Dividend Yield
- PYPD N/A
- VRAR N/A
- EPS Growth
- PYPD N/A
- VRAR N/A
- EPS
- PYPD N/A
- VRAR N/A
- Revenue
- PYPD N/A
- VRAR $8,756,789.00
- Revenue This Year
- PYPD N/A
- VRAR $6.59
- Revenue Next Year
- PYPD N/A
- VRAR $30.43
- P/E Ratio
- PYPD N/A
- VRAR N/A
- Revenue Growth
- PYPD N/A
- VRAR N/A
- 52 Week Low
- PYPD $2.30
- VRAR $0.50
- 52 Week High
- PYPD $4.49
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- PYPD 59.00
- VRAR 45.22
- Support Level
- PYPD $3.12
- VRAR $1.28
- Resistance Level
- PYPD $3.75
- VRAR $1.53
- Average True Range (ATR)
- PYPD 0.29
- VRAR 0.11
- MACD
- PYPD 0.01
- VRAR -0.03
- Stochastic Oscillator
- PYPD 69.83
- VRAR 22.27
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.